Thrivent Financial for Lutherans Invests $8.62 Million in Tema Oncology ETF (NASDAQ:CANC)

Thrivent Financial for Lutherans purchased a new stake in Tema Oncology ETF (NASDAQ:CANC) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 319,376 shares of the company’s stock, valued at approximately $8,616,000. Thrivent Financial for Lutherans owned approximately 19.01% of Tema Oncology ETF as of its most recent filing with the SEC.

Tema Oncology ETF Trading Up 0.6 %

Shares of NASDAQ:CANC opened at $28.25 on Friday. Tema Oncology ETF has a 1 year low of $21.26 and a 1 year high of $30.11. The firm has a fifty day moving average price of $28.98 and a 200 day moving average price of $27.83. The stock has a market capitalization of $47.46 million, a PE ratio of 26.86 and a beta of 1.11.

Tema Oncology ETF Company Profile

The Tema Oncology ETF (CANC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in stocks of companies focused on cancer treatment and management from issuers all around the world. The fund uses a bottom-up approach to select pioneering companies at perceived attractive valuations CANC was launched on Aug 15, 2023 and is issued by Tema.